OrthoPediatrics Corp. Files 8-K on Financials
Ticker: KIDS · Form: 8-K · Filed: May 6, 2024 · CIK: 1425450
| Field | Detail |
|---|---|
| Company | Orthopediatrics Corp (KIDS) |
| Form Type | 8-K |
| Filed Date | May 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00025 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: KIDS
TL;DR
OrthoPediatrics (KIDS) filed an 8-K with updated financial info.
AI Summary
OrthoPediatrics Corp. filed an 8-K on May 6, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. OrthoPediatrics Corp. is incorporated in Delaware and its common stock is traded on the Nasdaq Global Select Market under the ticker symbol KIDS.
Why It Matters
This 8-K filing provides investors with updated information on OrthoPediatrics Corp.'s financial performance and operational results, which can influence investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial information and does not indicate any unusual or significant risks.
Key Players & Entities
- OrthoPediatrics Corp. (company) — Registrant
- KIDS (company) — Trading Symbol
- Nasdaq Global Select Market (company) — Exchange
- May 6, 2024 (date) — Report Date
FAQ
What is the primary purpose of this 8-K filing for OrthoPediatrics Corp.?
The primary purpose of this 8-K filing is to report on OrthoPediatrics Corp.'s Results of Operations and Financial Condition, and it includes Financial Statements and Exhibits.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on May 6, 2024.
What is the trading symbol for OrthoPediatrics Corp. common stock?
The trading symbol for OrthoPediatrics Corp. common stock is KIDS.
On which exchange is OrthoPediatrics Corp. common stock listed?
OrthoPediatrics Corp. common stock is listed on the Nasdaq Global Select Market.
Where is OrthoPediatrics Corp. headquartered?
OrthoPediatrics Corp. is headquartered at 2850 Frontier Drive, Warsaw, Indiana 46582.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-05-06 16:16:08
Key Financial Figures
- $0.00025 — ange on which registered Common Stock, $0.00025 par value per share KIDS Nasdaq Global
Filing Documents
- kids-20240506.htm (8-K) — 27KB
- kidsq12024earningsrelease.htm (EX-99.1) — 176KB
- footera.jpg (GRAPHIC) — 17KB
- headera.jpg (GRAPHIC) — 12KB
- logoa.jpg (GRAPHIC) — 67KB
- 0001425450-24-000031.txt ( ) — 471KB
- kids-20240506.xsd (EX-101.SCH) — 2KB
- kids-20240506_def.xml (EX-101.DEF) — 3KB
- kids-20240506_lab.xml (EX-101.LAB) — 24KB
- kids-20240506_pre.xml (EX-101.PRE) — 15KB
- kids-20240506_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On May 6, 2024, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended March 31, 2024 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended March 31, 2024, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated May 6 , 202 4 issued by OrthoPediatrics Corp. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * * * * * * SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OrthoPediatrics Corp. Date: May 6, 2024 By: /s/ Daniel J. Gerritzen Daniel J. Gerritzen, General Counsel and Secretary - 2 -